4-Aminoquinolines block heme iron reactivity and interfere with artemisinin action
eLife · 2026
DOI: 10.7554/elife.108976 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Melissa Rosenthal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, United States. Hauptthemen laut MEDLINE: Artemisinins, Aminoquinolines, Heme, Antimalarials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Artemisinin-based combination therapies (ACTs) remain the mainstay of treatment for Plasmodium falciparum malaria, despite reports of ACT treatment failure. ACTs consist of an artemisinin and a longer-lived partner drug, which is often a quinoline. Given that heme is central to the mechanism of action of artemisinins and some quinolines, we hypothesized that these antimalarials would exhibit strong drug-drug interactions. Previous studies using standard 48 hr or 72 hr assays identified additive to mildly antagonistic interactions between artemisinins and quinolines. Here, we sought to re-evaluate these interactions using a pulsing assay that better mimics the short in vivo half-life of artemisinins. We found that chloroquine (CQ), piperaquine (PPQ), and amodiaquine substantially antagonize dihydroartemisinin (DHA), the active metabolite of artemisinins. CQ-DHA antagonism was notably exacerbated in CQ-resistant parasites, resulting in a superantagonistic phenotype in isobolograms. Further, we found that CQ co-treatment conferred artemisinin resistance to Kelch 13 wild-type parasites in the ring-stage survival assay. Using a small molecule probe (Ac-H-FluNox) to measure chemically reactive heme in live parasites, we determined that quinolines block artemisinin activation by rendering cytosolic heme inert. Finally, we probed beyond traditional ACTs, evaluating interactions of the proposed triple ACT, DHA-PPQ-mefloquine, as well as OZ439-quinoline combinations, which were all found to be antagonistic. Collectively, these in vitro data suggest that peroxide-quinolines may have liabilities as combination therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, United States.
- Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, United States.
ORCID-Profile: Melissa Rosenthal, Daniel E Goldberg
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Rosenthal, M., & Goldberg, D. E. (2026). 4-Aminoquinolines block heme iron reactivity and interfere with artemisinin action. eLife. https://doi.org/10.7554/elife.108976
Vancouver
Rosenthal M, Goldberg DE. 4-Aminoquinolines block heme iron reactivity and interfere with artemisinin action. eLife. 2026. doi:10.7554/elife.108976
BibTeX
@article{Rosenthal2026,
author = {Rosenthal, Melissa and Goldberg, Daniel E},
title = {4-Aminoquinolines block heme iron reactivity and interfere with artemisinin action},
journal = {eLife},
year = {2026},
doi = {10.7554/elife.108976}
}
EUVIMED